Article Details

Fresenius Kabi's Actemra® biosimilar Tyenne® (tocilizumab-aazg) Approved in the U.S.

Retrieved on: 2024-03-13 16:15:54

Tags for this article:

Click the tags to see associated articles and topics

Fresenius Kabi's Actemra® biosimilar Tyenne® (tocilizumab-aazg) Approved in the U.S.. View article details on hiswai:

Excerpt

On March 5, 2024, the FDA approved Fresenius Kabi's Tyenne® (tocilizumab-aazg) as a biosimilar of Chugai, Genentech and Hoffman-La Roche's ...

Article found on: www.jdsupra.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up